Articles: 1-10 of 65
Back to District Court? PTAB Strategic Recalibration in Patent Litigation
USA - February 18 2026 For years, parallel proceedings at the Patent Trial and Appeal Board (PTAB) were the near-automatic response of a defendant in district court patent…
Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays
USA - February 2 2026 Last year we discussed the implications of the Supreme Court’s choice not to review the Federal Circuit’s SnapRays decision for patent owners that…
Federal Circuit Eases Expert Admissibility Threshold
USA - January 28 2026 In a decision that is quickly gaining attention, the Federal Circuit held that the district court abused its discretion by excluding both of…
Supreme Court Takes Up Hikma v. Amarin: Induced Infringement and Skinny Labels in the Crosshairs
USA - January 21 2026 The Supreme Court’s decision to review Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc. places renewed attention on a familiar but unsettled…
Genesis Mission and New Guidance for AI-Assisted Inventions
USA - December 1 2025 The Federal government is Accelerating AI‑enabled innovation by launching the Genesis Mission, a sweeping national initiative to accelerate…
Federal Circuit Clarifies Limits of Issue Preclusion Between IPRs and District Courts
USA - October 27 2025 The Federal Circuit’s recent decision last week in Inland Diamond Prods. Co. v. Cherry Optical Inc., offers an important reminder for patent…
Patent Practitioners are Unsettled Regarding Seemingly-Settled Section 101 Jurisprudence
USA - October 20 2025 Patent eligibility under 35 U.S.C. § 101 should be a straightforward threshold question: any “new and useful process, machine, manufacture, or…
Stay Aware: Remote Employees Impact Venue Options In Patent Litigation
USA - October 14 2025 For many patent cases, the United States District Court hearing your patent dispute can have a big impact on case strategy, budget and management…
Novo Nordisk v. Mylan: Method of Treatment Claims Must Be Aligned with Label
USA - September 8 2025 Method-of-treatment (“MoT”) claims can be powerful tools for pharmaceutical companies seeking to extend market exclusivity for their products after…
Crypto Unlocked: New Patent Eligibility Guidance on Blockchain Technology
USA - September 3 2025 The U.S. gave crypto one of its biggest regulatory jolts in years. With the signing of the Guiding and Establishing National Innovation for U.S…
About The Patent Playbook
Featured authors
